• Jobs
  • Startups
  • Hire
LoginSign up

Formation Bio

Organization banner, image 1 of 3
Organization banner, image 2 of 3
Organization banner, image 3 of 3

Formation Bio has 23 open roles, 7 posted in the last 30 days. Funding stage: Series D. Last round: $372M, Jun 26, 2024.

Open roles

  • Formation Bio logo
    Manager, Cybersecurity

    Formation Bio

    • New York, NY +1 more
    • Hybrid · Senior
    AI-native
    Greenhouse
    Posted 7d ago
  • Formation Bio logo
    People Operations Manager

    Formation Bio

    • New York, NY +1 more
    • Hybrid · Senior
    Greenhouse
    Posted 9d ago
  • Formation Bio logo
    Director / Senior Director, DMPK

    Formation Bio

    • Boston, MA +1 more
    • Hybrid · Director / Executive
    Greenhouse
    Posted 11d ago
  • Formation Bio logo
    Business Development Operations Associate

    Formation Bio

    • Boston, MA +1 more
    • Junior
    AI-native
    Greenhouse
    Posted 17d ago
  • Formation Bio logo
    Associate Director, Business Development - Search & Evaluation

    Formation Bio

    • Boston, MA +1 more
    • Hybrid · Director / Executive
    Greenhouse
    Posted 22d ago
  • Formation Bio logo
    Data Scientist, Medical Imaging (Open Level)

    Formation Bio

    • Boston, MA +1 more
    • Hybrid · Senior
    AI-native
    Greenhouse
    Posted 23d ago
Show all roles
Unlock human wisdom
ThesisTermsPrivacy

About

Formation Bio logo

Formation Bio

Bringing new treatments to patients faster and more efficiently.

Formation Bio is an AI-native pharma company differentiated by radically more efficient drug development. The company has built proprietary technology platforms to optimize critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. Formation Bio acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop assets faster, unlock greater value per program and ultimately accelerate access to new treatments for patients. 2025 CNBC Disruptor 50 2025 Fierce 15 Award 2024 Endpoints 11 Award

Private companySeries D
Founded2013
HQNew York City, United States
Size51-200 employees
IndustryBiotechnology Research
Funding
  • Series D · $372M · Jun 26, 2024
Investors
Andreessen HorowitzFPV VenturesSequoia CapitalSV AngelThrive Capital
Tech stackiqvia, bedrock, neo4j, resonate, macos, wsl, microsoft-forefront, smartsheet, databricks, hashicorp-vault
News
  • Formation raises $600 million to fix AI's biotech bottleneck
  • Formation Bio unveils $600M fund to back more drug acquisitions
  • Formation Bio Announces $600 Million Debut Fund to Expand Drug Development Capacity
  • In a Twist, Venture-Backed Biotech Formation Bio Raises Its Own Investment Fund

Claim formation.bio

Work at formation.bio? Sign in to claim this org and manage its profile.

© 2026 Saywise Inc.